30 December 2004

Are Cell Phones a Health Risk?


Do you think cell phones a health risk? If yes, get a Green8, put it on your phone, and keep it away from your body. Ionizing radiation causes DNA breaks and chromosome aberrations which increase the risk of cancer. It is prudent to assume anything that causes the same thing is very risky. The cellphone industry reminds me of the cigarette industry 20 years ago. They kept saying we had not "proved" that cigarettes cause cancer. Eventually they started losing legal cases involving victims so "proof" probably depends more on a judge and jury than on science.

Researchers find DNA breaks from RF radiation
Jeffrey Silva, RCR Wireless News, 27 Dec 2004, p. 7

WASHINGTON--European researchers have found DNA breaks and chromosomal aberrations from radio-frequency radiation like that emitted from mobile phones, but they said new data does not prove handsets pose a health risk and called for more research...

"There was a strong postive correlation between both the intensity and duration of exposure to [RF radiation] and the increase in single- and double-strand DNA breaks and micronuclei frequencies" stated the study's summary.

26 December 2004

Mentoring Program Alert: Preventing Heart Disease by Vaccination with Oxidized LDL


Those in the electronic frequency research mentoring program need to (1) follow updates in the medical literature, (2) develop hypotheses of health problem causation, (3) develop frequency sets to test these hypothesis, (4) confirm that individuals with health problems respond to these frequency sets, and (5) repeatedly prevent or eliminate these health problems by providing solutions.

Let's consider the state of research in heart disease, particularly atherosclerosis. Leading researchers now assume this is caused by inflammation. That means there is likely to be a pathogen that causes inflammation and the health problem could be prevented by eliminating the pathogen.

Exercise 1: What is the pathogen?

Exercise 2: What is its frequency?

Hint: New Scientist reported this week that vaccination with oxidized LDL reduces the incidence of artherosclerotic plaque formation in mice by 70%. You don't have to be a rocket scientist to conclude that there is a pathogen in cells with oxidized LDL and that it could be eliminated by applying correct frequencies. Those who have studied the vaccination problem carefully know that it is a shock to the immune system with potential negative side effects. Developing easy means to kill the pathogen is more effective and avoids compromising the immune system. This should intensify research to identify the pathogen and find frequencies that easily exterminate it. Success in doing this puts you at least two steps ahead of conventional approaches to the problem. Since a single step in medicine requires an average of 17 years from publication to routine treatment, you will be 2x17 or 34 years ahead of the conventional paradigm if you can finish these exercises.

Vaccination could protect against heart disease
James Randerson, New Scientist, 22 December 2004

About 10 years ago, Jan Nilsson at Lund University in Sweden tried to provoke this immune response by giving oxidised LDL to mice. Oxidised LDL is the main form of the protein found in plaques, so Nilsson expected to see more atherosclerosis. But he was wrong. "To our surprise the mice were protected," he says.

This started him thinking that patients could be vaccinated against atherosclerosis, an idea that his group and Hansson's group have been working on independently. Both teams are using fragments of the oxidised form of LDL to prime the immune system to attack plaques when they first begin to form.

To test the idea, they have been injecting groups of mice with LDL fragments or a saline control. The mice given the LDL vaccination show as much as a 70% reduction in the number of plaques, and existing plaques appeared to stop growing, Nilsson and Hansson reported at the Cambridge meeting. There were no signs of any ill effects.

Libby, Peter. Atherosclerosis: The New View. Scientific American, May 2002, pp. 47-55.

PETER LIBBY, who earned his M.D. from the University of California, San Diego, is chief of cardiovascular medicine at Brigham and Women’s Hospital, Mallinckrodt Professor of Medicine at Harvard Medical School, and co-editor of the sixth edition of Heart Disease, a classic cardiology textbook (see “More to Explore,” on page 55). He regards “lifestyle modification as the cornerstone of cardiovascular prevention” and practices what he preaches by running recreationally, albeit, he says, more avidly than swiftly.

Scientists now agree that inflammation fuels the development and progression of atherosclerosis: the dangerous accumulation of fat-laden deposits, or plaques, in the arteries. The old view that fat builds up on passive artery walls is no longer tenable.

Inflammation can also cause certain plaques to rupture. Blood clots tend to form over ruptured plaques and can then occlude arteries, leading to such atherosclerotic complications as heart attack and stroke.

Excess low-density lipoprotein (LDL), or bad cholesterol, in the blood can trigger arterial inflammation. And cholesterol-lowering therapies already cornerstones of treatment for atherosclerosis can reduce it. Strategies that interfere with inflammation in other ways are under study as well.

A blood test that detects ongoing inflammation might prove useful as an adjunct to the cholesterol tests that doctors now employ to assess risk for heart attack and stroke.

22 December 2004

Cholesterol Drugs: Look at Alternatives

There are big dollars in cholesterol drugs and your doctor will not tell you that statins disrupt your CoQ10 pathway leading to higher risk of sudden heart failure. He or she also will not tell you that the Life Extension Foundation has a nutritional supplement protocol for lowering cholesterol that works well in combination with exercise. When my primary care physician wanted to put me on statin drugs a few years ago when my cholesterol hit 240, I told him I would be back in a few weeks with my cholesterol in normal range. The LEF protocol along with exercise brought it to 150. My physician was ecstatic and said he never saw anything like it! I thought it was too low (despite what some doctors will tell you) and work at maintaining it at 180.

I've replaced some of the LEF protocol with Dr. Sear's pharmaceutical grade fish oil which my tests indicate lowers my heart rate by 10 beats/minute along with a 5-10 point cholesterol drop within a few minutes of taking it. This is consistent with findings of the Lyon study. In 1994, the Lancet published the Lyon Diet Heart Study which showed that a mediterranean diet reduced mortality by 70%. This is a little better than statin drugs, many of which show only marginal effects. In 1999, one of the leading cardiologists at Massachusetts General Hospital reported in an editorial in Circulation that almost no cardiologists were familiar with the Lyon Heart Study. Circulation. 1999;99:733-735

Maybe cardiologists do read the medical literature but are confused by reading misinformation from guys on drug company payrolls at NIH.


The National Institutes of Health: Public Servant or Private Marketer?
By David Willman, Los Angeles Times Staff Writer

Doctors have long relied on the NIH to set medical standards. But with its researchers accepting fees and stock from drug companies, will that change? A continuing examination by The Times shows an unabashed mingling of science and commerce.

For 15 million Americans, it is a daily ritual: gulping down a pill to reduce cholesterol. They do it because their doctors tell them to. Their doctors, in turn, rely on recommendations from the National Institutes of Health and its scientists, such as Dr. H. Bryan Brewer Jr.

Brewer, as a leader at the NIH, was part of a team that gave the nation new cholesterol guidelines that were expected to prompt millions more people to take the daily pill. He also has written favorably of a specific brand of cholesterol medication, Crestor, which recently proved controversial.

What doctors were not told for years is this: While making recommendations in the name of the NIH, Brewer was working for the companies that sell the drugs. Government and company records show that from 2001 to 2003, he accepted about $114,000 in consulting fees from four companies making or developing cholesterol medications, including $31,000 from the maker of Crestor...

In the Aug. 21, 2003, American Journal of Cardiology, Brewer wrote that Crestor "produced markedly greater reductions" in cholesterol levels than three established competitor drugs tested in clinical trials. That was true. But Brewer also concluded that Crestor's "benefit-risk profile … appears to be very favorable," and that proved to be questionable.

Brewer assured doctors there was no basis for worry about a muscle-wasting side effect called rhabdomyolysis, which can cause kidney failure and death. (Another anticholesterol drug, Baycol, was removed from the market in 2001 after at least 31 deaths related to rhabdomyolysis were reported.)

Brewer wrote: "No cases of rhabdomyolysis occurred in patients receiving [Crestor] at 10 to 40" milligrams.

But eight cases of rhabdomyolysis were reported during clinical trials of Crestor. One of the case reports cited a patient who took the drug in 10-milligram doses, according to records filed with the Food and Drug Administration and reviewed by The Times under the Freedom of Information Act. Sales representatives for AstraZeneca have routinely provided copies of Brewer's journal article about Crestor to doctors nationwide, a company spokeswoman confirmed last week.

21 December 2004

Seaweed Stops Antibiotic Resistant Bacteria



Weeding Out Bacteria
By Kristen Philipkoski, MIT Technology Review, December 21, 2004

Slimy plant life floating around the ocean may hold the key to slowing down the spread of certain infections, and could lead to a new strain of drugs that won't be susceptible to antibiotic resistance, a problem the Centers for Disease Control calls one of its top concerns.

University of New South Wales researchers found that seaweed compounds, called furanones, can stop the bacteria that cause cholera by cutting off the communication systems enabling the disease to spread. The breakthrough has researchers speculating that furanones will likely also work against other bacteria, including those that cause staph infection, food poisoning and tuberculosis -- which are increasingly becoming resistant to some antibiotics.

According to the CDC, every year nearly two million people in the United States get infections in the hospital, and 90,000 die. And 70 percent of the bacteria that cause these infections are resistant to at least one antibiotic.

But researchers say bacteria won't have an incentive to develop mutations that will foil furanones because they don’t actually kill bacteria, only block their communication with each other, which prevents them from growing strong enough to cause problems.

11 December 2004

Case Analysis: Health Hazards of Plutonium Release


During the time I was Asst. Professor of Radiology, Biometrics, and Preventive Medicine at the University of Colorado, I was appointed by Governor Lamm and Congressman (later Senator) Tim Wirth to serve for many years as Chair of the Subcommittee on Health Effects of the Rocky Flats Monitoring Committee.

The Rocky Flats Plant in the Denver area made virtually all of the plutonium triggers for nuclear weapons during the cold war. Fires in the plant on multiple occasions had dispersed plutonium into the suburban surroundings. Since I was funded by the National Cancer Institute to work with leading carcinogenesis researchers in the world to identify causes and cures for cancer, I applied my mathematical models of tumor formation to the Rocky Flats case.

This research is highly relevant to research on use of electromagnetic frequencies to kill cancer cells. Since many people have asked for specifics in my research background, I recently posted an overview paper:

Sutherland JV (1984) Estimates of cancer risk associated with radiation exposure. In Health Effects of Low Level Radiation. Hendee WR (Ed) Norwalk: Appleton-Century-Crofts, pp 93-117.

Scientific papers published before the era of online journals are difficult to access so I am posting as I have time to scan them. Here is the paper on Rocky Flats. It shows that, while plutonium exposure undoubtedly increased the risk of cancer in the suburban population around the plant, the risk increase was small compared to cancer risk induced by smoking.

Sutherland JV (1984) Case Analysis: Health Hazards of Plutonium Release from the Rocky Flats Plant. In Health Effects of Low Level Radiation. Hendee WR (Ed) Norwalk: Appleton-Century-Crofts, pp 93-117.

09 December 2004

Parasites: Using Electromagnetic Devices to Kill Them

Over the past decade, I've eliminated thousands of parasite infections. Everyone has at least several of them. Most go unnoticed.

This week I've provided frequencies for some very interesting parasite infections caused by herbal protocols that cleared them out of the intestinal tract, only to have them migrate to another part of the body.

To eliminate parasites requires the precise frequency for each stage of the parasite life cycle (at least four, often seven or more). This requires careful testing of the person along with the specific parasite strain, which can be done remotely with a high resolution digital photo.

General frequencies and zappers usually annoy parasites rather than kill them, often stimulating them to move around and proliferate. Also, killing one parasite, or one strain of a parasite allows other strains to proliferate. And killing a parasite infected with another parasite, virus, bacteria, etc., releases those pathogens into your system. Taking the random frequency or shotgun approach to parasites can generate a major Herxheimer reaction.

So usually, I figure out what the parasite are infected with and kill that first. Then shoot the parasite in all its stages. Then watch for what starts to proliferate and kill that. While herbal protocols will usually clean out your digestive tract, the parasites will often move to other parts of your body, particularly the brain and sometimes veins which can cause blood pressure and high pulse. Athlete's foot parasites seem to have a particular affinity for the brain, maybe one of the factors in the "jock" personal type. So you really want to use frequency devices that provide a whole body effect. The right herbs are a good adjuvant therapy to keep the body loading down while you eliminate the stragglers with frequency devices.

Finally, a parasite may hole up in a very specific organ or portion of an organ system and nothing will eliminate it without plate zapping. So you need to have a means of detecting where in the body a specific parasite is hiding, figuring out what it is infected with, determining the stages of its life cycle and the specific frequencies for those stages, along with slightly different frequencies for different strains of the same parasite.

It's a daunting task. As a result, most people do not get consistent results with Rife frequencies for parasites without some expert assistance.

04 December 2004

Political Failure Will Keep Medical Error the Third Leading Cause of Death


Health Care Technology Is a Promise Unfinanced
December 3, 2004
By STEVE LOHR

From the president on down, the Bush administration has been a proponent of modernizing the nation's creaky healthcare system with information technology. But while the administration's words of support for ahigh-technology future for health care have been plentiful, the dollars, it seems, are scarce. The huge federal spending bill recently approved by Congress eliminated a seemingly modest $50 million request for the office of Dr. David J. Brailer, who was appointed the national health information technology coordinator in May.

Dr. Brailer acknowledged his disappointment in an interview yesterday. "The money is important," he said. "This was a bad bounce, and it shows how big our education challenge is." One critic of the action was less guarded in his comments. "Congress, in its infinite wisdom, zeroed-out DavidBrailer's office," said Newt Gingrich, the Republican Health Transformation, a health policy group. "They couldn't find $50 million to signal that David Brailer has a real job and what he's doing is important. Frankly, I think it 's a disgrace."

The Bush administration, Mr. Gingrich said, bore most of the responsibility. "No one in the White House or in the senior staff of the Department of Health and Human Services fought for this," he said.

...The $50 million requested for Dr. Brailer's office was to have been used to provide seed money for health information demonstration projects that would encourage the industry to agree on technology standards, hasten investment by private companies and accelerate the adoption of modern information technology by doctors and hospitals.

Bringing patient records and prescriptions out of an era of ink and paper into the computer age, health experts agree, would make health care more efficient and reduce medical errors, saving lives and dollars. President Bush repeatedly sounded that theme this year, starting with his State of the Union address. "By computerizing health records," he said, "we can avoid dangerous medical mistakes, reduce costs and improve care."

In a debate with Senator John Kerry in October, Mr. Bush said that much of the high and rising cost of health care resulted from hospitals, clinics and doctors' not using "any information technology." Health care, he asserted, was trapped in the past, the "equivalent of buggy-and-horse days, compared with other industries here in America."

"We've got to introduce high technology into health care," the president added. "We're beginning to do it."